---
figid: PMC6833007__jcm-08-01615-g001
figlink: /pmc/articles/PMC6833007/figure/jcm-08-01615-f001/
number: F1
caption: 'Mechanisms involved in activation and regulation of NLRP3 canonical pathway.
  NLRP3 inflammasome activation requires two signals. The “priming” signal is triggered
  by PAMP/DAMP recognition by PPRs (e.g. TLRs) and certain cytokines (e.g. TNF-α,
  IL-1β) and activates NF-κB in the cell nucleus. This leads to NLRP3, pro-IL1-β and
  pro-IL-18 gene transcription. The second signal induces the assembly of NLRP3, ASC,
  and caspase-1 to form an active NLRP3 inflammasome and ultimately leads to the release
  of mature IL-1β and IL-18. Gasdermin D is cleaved and becomes inserted into the
  cell membrane, forming pores and inducing pyroptosis. The mechanisms proposed for
  the second NLRP3 activating signals are shown and include: a) changes in cytosolic
  levels of ions, such as K+, Cl- and Ca+2, b) lysosomal destabilization and the release
  of cathepsins, c) mitochondrial dysfunction-derived signals such as mtROS, mtDNA
  and d) metabolic changes. PtdIns4P on dTGN drive NLRP3 activation. Aerobic glycolysis
  pathways and the TCA cycle also activate NLRP3. Autophagy and mitophagy inhibit
  NLRP3 inflammasome activation. IFNs also inhibit NLRP3 activation through NO production.
  IL-1R, IL-1β receptor; TLR, Toll-like receptor; TNFR, tumor necrosis factor receptor;
  IFNAR, IFNα/β receptor; NEK7, NIMA- related kinase 7; NF- κB, nuclear factor- κB;
  P2X7, P2X purinoceptor 7; PtdIns4P, phosphatidylinositol-4-phosphate; PYD, pyrin
  domain; ROS, reactive oxygen species; HK1, hexokinase; mTORC1, rapamycin complex
  1; SDH, succinate dehydrogenase; EIF2AK2, eukaryotic translation initiation factor
  2-alpha kinase 2.'
pmcid: PMC6833007
papertitle: Targeting NLRP3 Inflammasome Activation in Severe Asthma.
reftext: Efthymia Theofani, et al. J Clin Med. 2019 Oct;8(10):1615.
pmc_ranked_result_index: '115072'
pathway_score: 0.8889369
filename: jcm-08-01615-g001.jpg
figtitle: Mechanisms involved in activation and regulation of NLRP3 canonical pathway
year: '2019'
organisms: Homo sapiens
ndex: a13814aa-df0c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6833007__jcm-08-01615-g001.html
  '@type': Dataset
  description: 'Mechanisms involved in activation and regulation of NLRP3 canonical
    pathway. NLRP3 inflammasome activation requires two signals. The “priming” signal
    is triggered by PAMP/DAMP recognition by PPRs (e.g. TLRs) and certain cytokines
    (e.g. TNF-α, IL-1β) and activates NF-κB in the cell nucleus. This leads to NLRP3,
    pro-IL1-β and pro-IL-18 gene transcription. The second signal induces the assembly
    of NLRP3, ASC, and caspase-1 to form an active NLRP3 inflammasome and ultimately
    leads to the release of mature IL-1β and IL-18. Gasdermin D is cleaved and becomes
    inserted into the cell membrane, forming pores and inducing pyroptosis. The mechanisms
    proposed for the second NLRP3 activating signals are shown and include: a) changes
    in cytosolic levels of ions, such as K+, Cl- and Ca+2, b) lysosomal destabilization
    and the release of cathepsins, c) mitochondrial dysfunction-derived signals such
    as mtROS, mtDNA and d) metabolic changes. PtdIns4P on dTGN drive NLRP3 activation.
    Aerobic glycolysis pathways and the TCA cycle also activate NLRP3. Autophagy and
    mitophagy inhibit NLRP3 inflammasome activation. IFNs also inhibit NLRP3 activation
    through NO production. IL-1R, IL-1β receptor; TLR, Toll-like receptor; TNFR, tumor
    necrosis factor receptor; IFNAR, IFNα/β receptor; NEK7, NIMA- related kinase 7;
    NF- κB, nuclear factor- κB; P2X7, P2X purinoceptor 7; PtdIns4P, phosphatidylinositol-4-phosphate;
    PYD, pyrin domain; ROS, reactive oxygen species; HK1, hexokinase; mTORC1, rapamycin
    complex 1; SDH, succinate dehydrogenase; EIF2AK2, eukaryotic translation initiation
    factor 2-alpha kinase 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PYCARD
  - EIF2AK2
  - SETD2
  - IFNA1
  - IFNAR1
  - IL10
  - IL16
  - IL18
  - IL1A
  - IL1R1
  - IRF6
  - MTOR
  - RPTOR
  - NFKB1
  - PKM
  - SDHB
  - SIRT2
  - TLR10
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TNFRSF1A
  - ATP
  - Ca
  - Succinate
  - TCA
  - NAD
  - Pyruvate
  - lactate
  - LPS
genes:
- word: ASC
  symbol: ASC
  source: hgnc_alias_symbol
  hgnc_symbol: PYCARD
  entrez: '29108'
- word: EIF2AK2
  symbol: EIF2AK2
  source: hgnc_symbol
  hgnc_symbol: EIF2AK2
  entrez: '5610'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNAR
  symbol: IFNAR
  source: hgnc_prev_symbol
  hgnc_symbol: IFNAR1
  entrez: '3454'
- word: IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: IL-16
  symbol: IL-16
  source: hgnc_alias_symbol
  hgnc_symbol: IL16
  entrez: '3603'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-1A
  symbol: IL-1A
  source: hgnc_alias_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: (LPS)
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: -PKM2
  symbol: PKM2
  source: hgnc_prev_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: SDH
  symbol: SDH
  source: hgnc_prev_symbol
  hgnc_symbol: SDHB
  entrez: '6390'
- word: Sirt2
  symbol: SIRT2
  source: hgnc_symbol
  hgnc_symbol: SIRT2
  entrez: '22933'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TNFR
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
chemicals:
- word: ATP
  source: MESH
  identifier: D000255
- word: Ca
  source: MESH
  identifier: D002118
- word: Succinate
  source: MESH
  identifier: D013386
- word: TCA
  source: MESH
  identifier: C000589078
- word: NAD
  source: MESH
  identifier: D009243
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: lactate
  source: MESH
  identifier: D019344
diseases:
- word: LPS
  source: MESH
  identifier: C536528
figid_alias: PMC6833007__F1
redirect_from: /figures/PMC6833007__F1
figtype: Figure
---
